Yokohama City University Hospital

Kanagawa 236-0004

2 studies enrolling now · 9 studies all time

What they study most

Acute Myocardial Infarction (AMI), Carcinoma, Renal Cell, Cardiovascular Risk, Cervical Cancer, Dermatomyositis, Fallopian Tube Cancer, Follicular Lymphoma, Large B-cell Lymphoma, Ovarian Cancer, Peritoneal Neoplasms, Pulmonary Arterial Hypertension, Renal Cell Carcinoma

Studies at this site

• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel — Available (expanded access)
• A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension — Running, not enrolling
• Vamikibart in Participants With Uveitic Macular Edema — Completed
• A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment — Stopped early
• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) — Completed
• Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis — Completed